Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, today reported financial results for ...

Biotech player PYC Therapeutics (ASX:PYC) has dosed its first patient in a clinical trial seeking to ameliorate symptoms of ...

PYC Therapeutics Limited (AU:PYC) has released an update. PYC Therapeutics has dosed its first patient in a clinical trial for its innovative ...

A 12-YEAR-OLD boy has been left blind because he would only eat burgers and doughnuts. The unnamed child who lived in the US ...

The most common of these syndromes include hearing loss or obesity, as well as retinal degeneration and/or optic atrophy, and some not only severely affect the overall quality of life of patients ...

LUNA and 4-year OPTIC data, alongside Phase 3 trial design updates, anticipated in Q4 2024- Appointed Jason Mitchell as chief ...

Progressive muscular atrophy (PMA) is a rare disease that affects lower motor neurons, brain cells that provide muscles and glands with the nerves needed to function correctly. People with this ...

Removing drops from procedure increases adherence and comfort for most patients.

Jibran Sharieff, MD, and Brandon Kingrey, MD, discuss their innovative smartphone-based device for affordable retinal imaging, highlighting its potential to enhance eye care accessibility and ...

Lack of pain Ischemic optic neuropathy, NMO-associated optic neuritis, LHON, Susac syndrome, various maculopathies Disc hemorrhages Ischemic optic neuropathy, inflammatory optic neuritis ...